Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.
An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.
A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.
Page 1: Executive Summary
Introduction
Page 2: Major OTC segments
Market Overview
Page 3: Global OTC Drug Market - Overview, Size, & Growth (Value: 2009-15e), Distribution figures (2009)
Page 4: Top 10 global OTC brands - Names & sales figures (2009)
Page 5: Indian OTC Drug Market- Overview, Size & Growth (Value: 2010-2015e), Distribution figures (2009)
Page 6: Top 10 Indian OTC brands - Names & sales figures (2009)
Page 7: Vitamins & minerals and Gastrointestinals market - Overview, Size & Growth
Page 8: Cough & cold and Analgesics market - Overview, Size & Growth
Page 9: Dermatologicals and Lifestyle OTC market - Overview, Size & Growth
Drivers & Challenges
Page 10: Summary
Page 11-16: Drivers
Page 17-18: Challenges
Government initiatives
Page 19: Summary
Page 20-21: Government Initiatives
Market value chain, regulation and patents
Page 22: Pharmaceutical value chain
Page 23: Phases of clinical trials
Page 24: Drug regulations
Page 25: Regulatory frameworks
Competition
Page 26-31: Major domestic players
Page 32-39: Major foreign players
Page 40: Recent Developments
Strategic recommendation
Page 41-42: Strategic Recommendations
Request Sample 
Request Discount 
Inquire Before Buy
